Rubicon Organics to Acquire Cultivation Facility in BC to Strengthen Leadership in Premium Cannabis
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) has announced plans to acquire a 47,500 square foot indoor cultivation facility in Hope, British Columbia from Medipharm Labs Inc. The purchase agreement is valued at $4.5 million and is subject to due diligence, financing, and board approval.
The acquisition of the Hope Facility represents a strategic move to expand the company's premium production capacity. The purpose-built facility will be used to increase production capabilities and meet growing demand for Rubicon's leading brand portfolio. The transaction is expected to close in the second quarter of 2025.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) ha annunciato piani per acquisire una struttura di coltivazione indoor di 47.500 piedi quadrati a Hope, Columbia Britannica, da Medipharm Labs Inc. L'accordo di acquisto ha un valore di 4,5 milioni di dollari ed è soggetto a due diligence, finanziamento e approvazione del consiglio.
L'acquisizione della struttura di Hope rappresenta una mossa strategica per espandere la capacità produttiva premium dell'azienda. La struttura progettata appositamente sarà utilizzata per aumentare le capacità produttive e soddisfare la crescente domanda per il portafoglio di marchi leader di Rubicon. Si prevede che la transazione si chiuda nel secondo trimestre del 2025.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) ha anunciado planes para adquirir una instalación de cultivo interior de 47,500 pies cuadrados en Hope, Columbia Británica, de Medipharm Labs Inc. El acuerdo de compra está valorado en 4.5 millones de dólares y está sujeto a la debida diligencia, financiamiento y aprobación de la junta.
La adquisición de la instalación de Hope representa un movimiento estratégico para expandir la capacidad de producción premium de la empresa. La instalación diseñada específicamente se utilizará para aumentar las capacidades de producción y satisfacer la creciente demanda del portafolio de marcas líderes de Rubicon. Se espera que la transacción se cierre en el segundo trimestre de 2025.
루비콘 오가닉스 (TSXV: ROMJ) (OTCQX: ROMJF)는 메디파름 랩스(Medipharm Labs Inc.)로부터 브리티시컬럼비아주 호프에 위치한 47,500 평방피트의 실내 재배 시설을 인수할 계획을 발표했습니다. 구매 계약은 450만 달러로 평가되며, 실사, 자금 조달 및 이사회 승인이 필요합니다.
호프 시설의 인수는 회사의 프리미엄 생산 능력을 확장하기 위한 전략적 조치를 나타냅니다. 이 특별히 설계된 시설은 생산 능력을 증가시키고 루비콘의 선도적인 브랜드 포트폴리오에 대한 증가하는 수요를 충족하는 데 사용될 것입니다. 거래는 2025년 2분기에 종료될 것으로 예상됩니다.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) a annoncé des projets d'acquisition d'une installation de culture intérieure de 47 500 pieds carrés à Hope, en Colombie-Britannique, auprès de Medipharm Labs Inc. Le contrat d'achat est évalué à 4,5 millions de dollars et est soumis à la due diligence, au financement et à l'approbation du conseil d'administration.
L'acquisition de l'installation de Hope représente un mouvement stratégique pour étendre la capacité de production premium de l'entreprise. L'installation conçue sur mesure sera utilisée pour augmenter les capacités de production et répondre à la demande croissante pour le portefeuille de marques leaders de Rubicon. La transaction devrait être finalisée au deuxième trimestre de 2025.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) hat Pläne angekündigt, eine 47.500 Quadratfuß große Innenanbauanlage in Hope, British Columbia, von Medipharm Labs Inc. zu erwerben. Der Kaufvertrag hat einen Wert von 4,5 Millionen Dollar und unterliegt der Due Diligence, der Finanzierung und der Genehmigung durch den Vorstand.
Die Übernahme der Hope-Anlage stellt einen strategischen Schritt dar, um die Premium-Produktionskapazität des Unternehmens zu erweitern. Die speziell entwickelte Anlage wird genutzt, um die Produktionskapazitäten zu erhöhen und der wachsenden Nachfrage nach Rubicons führendem Markenportfolio gerecht zu werden. Es wird erwartet, dass die Transaktion im zweiten Quartal 2025 abgeschlossen wird.
- Strategic expansion of production capacity with 47,500 sq ft facility
- Ready-to-use operational facility requiring no construction time
- Addresses growing demand for premium products
- Requires $4.5M capital outlay
- Subject to financing condition indicating potential funding needs
- Integration and operational transition risks
VANCOUVER, British Columbia, March 03, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, is pleased to announce that it has entered into a purchase and sale agreement (the “PSA”) with Medipharm Labs Inc. in which Rubicon Organics intends to acquire an operational, purpose-built 47,500 square foot indoor cultivation facility in Hope, British Columbia (the “Hope Facility”).
“Acquiring the Hope Facility is a milestone for Rubicon Organics and further strengthens our premium production capacity setting up Rubicon Organics to service the growing demand for our leading brand portfolio, and accelerating our growth beyond our existing footprint,” said Margaret Brodie, Chief Executive Officer.
Pursuant to the terms of the PSA, the purchase price for the Hope Facility is
About the Hope Facility
The Hope Facility spans 47,500 square feet of purpose-built indoor capacity, and is equipped with advanced cultivation technology, supporting Rubicon Organics’ strategy to expand its premium product offerings and increasing supply to meet rising demand. The Company estimates annual production capacity of the Hope Facility to be up to 4,500 kgs and expects Rubicon Organics’ first harvests in 2025.
The Company will provide further updates on the transaction and production timelines in the coming months.
ABOUT RUBICON ORGANICS INC.
Rubicon Organics Inc. is the global brand leader in premium organic cannabis products. The Company is vertically integrated through its wholly owned subsidiary Rubicon Holdings Corp, a licensed producer. Rubicon Organics is focused on achieving industry leading profitability through its premium cannabis flower, product innovation and brand portfolio management, including three flagship brands: its super-premium brand Simply Bare™ Organic, its premium brand 1964 Supply Co™, and its cannabis wellness brand Wildflower™ in addition to the Company’s mainstream brand Homestead Cannabis Supply™.
The Company ensures the quality of its supply chain by cultivating, processing, branding and selling organic certified, sustainably produced, super-premium cannabis products from its state-of-the-art glass roofed facility located in Delta, BC, Canada.
CONTACT INFORMATION
Margaret Brodie
CEO
Phone: +1 (437) 929-1964
Email: ir@rubiconorganics.com
The TSX Venture Exchange or its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release.
Cautionary Statement Regarding Forward Looking Information
This press release contains forward-looking information within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Rubicon Organics’ goal of achieving industry leading profitability are “forward-looking statements”. Forward-looking information can be identified by the use of words such as “will” or variations of such word or statements that certain actions, events or results “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. The forward-looking information in this press release is based on certain assumptions that management considers reasonable under the circumstances, including the Company’s acquisition of the Hope Facility, the Hope Facility strengthening the Company’s premium production capacity, growing demand of the Company’s leading brand portfolio, the acceleration of the Company’s growth beyond its existing footprint, the intended use of the Hope Facility, the ability of the Company to successfully complete the acquisition of the Hope Facility and the expected timing of completion of the acquisition of the Hope Facility. These assumptions include securing necessary financing, the impact of the Hope Facility on the Company’s business, completing due diligence, obtaining required regulatory approvals such as licensing, and fulfilling other customary closing conditions. These statements are based on current expectations, estimates, and projections about the Company’s business and the industry in which it operates. Risks and uncertainties associated with the forward-looking information in this press release include, among others, risks related to regulatory approvals, changes in market conditions, competition, supply chain disruptions, the Company's ability to maintain certification standards, and the successful implementation of its business strategy. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Rubicon Organics has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Rubicon Organics assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.
FAQ
How much is Rubicon Organics (ROMJF) paying for the Hope Facility acquisition?
When will ROMJF complete the Hope Facility acquisition?
What is the size of the new cultivation facility ROMJF is acquiring?
What are the conditions for ROMJF's Hope Facility acquisition?
